Advertisement

Research Article Free access | 10.1172/JCI107162

Parathyroid Function in Primary Osteoporosis

B. Lawrence Riggs, Claude D. Arnaud, Jenifer Jowsey, Ralph S. Goldsmith, and Patrick J. Kelly

1Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Find articles by Riggs, B. in: JCI | PubMed | Google Scholar

1Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Find articles by Arnaud, C. in: JCI | PubMed | Google Scholar

1Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Find articles by Jowsey, J. in: JCI | PubMed | Google Scholar

1Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Find articles by Goldsmith, R. in: JCI | PubMed | Google Scholar

1Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

Find articles by Kelly, P. in: JCI | PubMed | Google Scholar

Published January 1, 1973 - More info

Published in Volume 52, Issue 1 on January 1, 1973
J Clin Invest. 1973;52(1):181–184. https://doi.org/10.1172/JCI107162.
© 1973 The American Society for Clinical Investigation
Published January 1, 1973 - Version history
View PDF
Abstract

Two major species of serum immunoreactive parathyroid hormone (iPTH) were measured in 47 untreated patients with primary osteoporosis by using two highly specific radioimmunoassays. Mean iPTH was normal with one antiserum but was lower than normal (P < 0.001) with the other, iPTH values did not correlate with biochemical parameters or with the proportion of bone-resorbing surfaces in iliac crest bone biopsy specimens. These data suggest that the increased bone resorption is not due to increased parathyroid function in most osteoporotic patients. However, seven of our patients (15%) appear to represent a separate population because they had increased values with one or the other of the antisera.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (January 1, 1973): No description
Advertisement
Advertisement